Home > > > Report Detail

Global Lentiviral Vector In Gene Therapy Market Growth 2020-2025

Publisher Name :
Date: 13-Oct-2020
No. of pages: 131

According to this study, over the next five years the Lentiviral Vector In Gene Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Lentiviral Vector In Gene Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Lentiviral Vector In Gene Therapy market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Lentiviral Vector In Gene Therapy, covering the supply chain analysis, impact assessment to the Lentiviral Vector In Gene Therapy market size growth rate in several scenarios, and the measures to be undertaken by Lentiviral Vector In Gene Therapy companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Retrovirus (RV)

- Adenovirus (AdV)

- Adeno-associated Virus (AAV)

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Hospital

- Clinic

- Research Institution

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Thermo Fisher Scientific Sirion-Biotech GmbH

- Vigene Biosciences

- SignaGen Laboratories

- Takara Bio

- OriGene Technologies

- GENEMEDI

- Cell Biolabs

- Bluebird Bio

- GenTarget

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Lentiviral Vector In Gene Therapy consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Lentiviral Vector In Gene Therapy market by identifying its various subsegments.

- Focuses on the key global Lentiviral Vector In Gene Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Lentiviral Vector In Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Lentiviral Vector In Gene Therapy submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Lentiviral Vector In Gene Therapy Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lentiviral Vector In Gene Therapy Consumption 2015-2025
2.1.2 Lentiviral Vector In Gene Therapy Consumption CAGR by Region
2.2 Lentiviral Vector In Gene Therapy Segment by Type
2.2.1 Retrovirus (RV)
2.2.2 Adenovirus (AdV)
2.2.3 Adeno-associated Virus (AAV)
2.3 Lentiviral Vector In Gene Therapy Consumption by Type
2.3.1 Global Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
2.3.2 Global Lentiviral Vector In Gene Therapy Revenue and Market Share by Type (2015-2020)
2.3.3 Global Lentiviral Vector In Gene Therapy Sale Price by Type (2015-2020)
2.4 Lentiviral Vector In Gene Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institution
2.4.4 Others
2.5 Lentiviral Vector In Gene Therapy Consumption by Application
2.5.1 Global Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
2.5.2 Global Lentiviral Vector In Gene Therapy Value and Market Share by Type (2015-2020)
2.5.3 Global Lentiviral Vector In Gene Therapy Sale Price by Type (2015-2020)

3 Global Lentiviral Vector In Gene Therapy by Company
3.1 Global Lentiviral Vector In Gene Therapy Sales Market Share by Company
3.1.1 Global Lentiviral Vector In Gene Therapy Sales by Company (2018-2020)
3.1.2 Global Lentiviral Vector In Gene Therapy Sales Market Share by Company (2018-2020)
3.2 Global Lentiviral Vector In Gene Therapy Revenue Market Share by Company
3.2.1 Global Lentiviral Vector In Gene Therapy Revenue by Company (2018-2020)
3.2.2 Global Lentiviral Vector In Gene Therapy Revenue Market Share by Company (2018-2020)
3.3 Global Lentiviral Vector In Gene Therapy Sale Price by Company
3.4 Global Lentiviral Vector In Gene Therapy Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Lentiviral Vector In Gene Therapy Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Lentiviral Vector In Gene Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Lentiviral Vector In Gene Therapy by Regions
4.1 Lentiviral Vector In Gene Therapy by Regions
4.2 Americas Lentiviral Vector In Gene Therapy Consumption Growth
4.3 APAC Lentiviral Vector In Gene Therapy Consumption Growth
4.4 Europe Lentiviral Vector In Gene Therapy Consumption Growth
4.5 Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Growth

5 Americas
5.1 Americas Lentiviral Vector In Gene Therapy Consumption by Countries
5.1.1 Americas Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020)
5.1.2 Americas Lentiviral Vector In Gene Therapy Value by Countries (2015-2020)
5.2 Americas Lentiviral Vector In Gene Therapy Consumption by Type
5.3 Americas Lentiviral Vector In Gene Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Lentiviral Vector In Gene Therapy Consumption by Regions
6.1.1 APAC Lentiviral Vector In Gene Therapy Consumption by Regions (2015-2020)
6.1.2 APAC Lentiviral Vector In Gene Therapy Value by Regions (2015-2020)
6.2 APAC Lentiviral Vector In Gene Therapy Consumption by Type
6.3 APAC Lentiviral Vector In Gene Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Lentiviral Vector In Gene Therapy by Countries
7.1.1 Europe Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020)
7.1.2 Europe Lentiviral Vector In Gene Therapy Value by Countries (2015-2020)
7.2 Europe Lentiviral Vector In Gene Therapy Consumption by Type
7.3 Europe Lentiviral Vector In Gene Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Lentiviral Vector In Gene Therapy by Countries
8.1.1 Middle East & Africa Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Lentiviral Vector In Gene Therapy Value by Countries (2015-2020)
8.2 Middle East & Africa Lentiviral Vector In Gene Therapy Consumption by Type
8.3 Middle East & Africa Lentiviral Vector In Gene Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Lentiviral Vector In Gene Therapy Distributors
10.3 Lentiviral Vector In Gene Therapy Customer

11 Global Lentiviral Vector In Gene Therapy Market Forecast
11.1 Global Lentiviral Vector In Gene Therapy Consumption Forecast (2021-2025)
11.2 Global Lentiviral Vector In Gene Therapy Forecast by Regions
11.2.1 Global Lentiviral Vector In Gene Therapy Forecast by Regions (2021-2025)
11.2.2 Global Lentiviral Vector In Gene Therapy Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Lentiviral Vector In Gene Therapy Forecast by Type
11.8 Global Lentiviral Vector In Gene Therapy Forecast by Application

12 Key Players Analysis
12.1 Thermo Fisher Scientific Sirion-Biotech GmbH
12.1.1 Company Information
12.1.2 Lentiviral Vector In Gene Therapy Product Offered
12.1.3 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Scientific Sirion-Biotech GmbH Latest Developments
12.2 Vigene Biosciences
12.2.1 Company Information
12.2.2 Lentiviral Vector In Gene Therapy Product Offered
12.2.3 Vigene Biosciences Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Vigene Biosciences Latest Developments
12.3 SignaGen Laboratories
12.3.1 Company Information
12.3.2 Lentiviral Vector In Gene Therapy Product Offered
12.3.3 SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 SignaGen Laboratories Latest Developments
12.4 Takara Bio
12.4.1 Company Information
12.4.2 Lentiviral Vector In Gene Therapy Product Offered
12.4.3 Takara Bio Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Takara Bio Latest Developments
12.5 OriGene Technologies
12.5.1 Company Information
12.5.2 Lentiviral Vector In Gene Therapy Product Offered
12.5.3 OriGene Technologies Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 OriGene Technologies Latest Developments
12.6 GENEMEDI
12.6.1 Company Information
12.6.2 Lentiviral Vector In Gene Therapy Product Offered
12.6.3 GENEMEDI Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GENEMEDI Latest Developments
12.7 Cell Biolabs
12.7.1 Company Information
12.7.2 Lentiviral Vector In Gene Therapy Product Offered
12.7.3 Cell Biolabs Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Cell Biolabs Latest Developments
12.8 Bluebird Bio
12.8.1 Company Information
12.8.2 Lentiviral Vector In Gene Therapy Product Offered
12.8.3 Bluebird Bio Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Bluebird Bio Latest Developments
12.9 GenTarget
12.9.1 Company Information
12.9.2 Lentiviral Vector In Gene Therapy Product Offered
12.9.3 GenTarget Lentiviral Vector In Gene Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GenTarget Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Lentiviral Vector In Gene Therapy Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Retrovirus (RV)
Table 5. Major Players of Adenovirus (AdV)
Table 6. Major Players of Adeno-associated Virus (AAV)
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
Table 9. Global Lentiviral Vector In Gene Therapy Revenue by Type (2015-2020) ($ million)
Table 10. Global Lentiviral Vector In Gene Therapy Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Lentiviral Vector In Gene Therapy Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Lentiviral Vector In Gene Therapy Consumption Market Share by Application (2015-2020)
Table 14. Global Lentiviral Vector In Gene Therapy Value by Application (2015-2020)
Table 15. Global Lentiviral Vector In Gene Therapy Value Market Share by Application (2015-2020)
Table 16. Global Lentiviral Vector In Gene Therapy Sale Price by Application (2015-2020)
Table 17. Global Lentiviral Vector In Gene Therapy Sales by Company (2017-2019) (K Units)
Table 18. Global Lentiviral Vector In Gene Therapy Sales Market Share by Company (2017-2019)
Table 19. Global Lentiviral Vector In Gene Therapy Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Company (2017-2019)
Table 21. Global Lentiviral Vector In Gene Therapy Sale Price by Company (2017-2019)
Table 22. Global Lentiviral Vector In Gene Therapy Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Lentiviral Vector In Gene Therapy Products Offered
Table 24. Lentiviral Vector In Gene Therapy Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Lentiviral Vector In Gene Therapy Consumption by Regions 2015-2020 (K Units)
Table 26. Global Lentiviral Vector In Gene Therapy Consumption Market Share by Regions 2015-2020
Table 27. Global Lentiviral Vector In Gene Therapy Value by Regions 2015-2020 ($ Millions)
Table 28. Global Lentiviral Vector In Gene Therapy Value Market Share by Regions 2015-2020
Table 29. Americas Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Lentiviral Vector In Gene Therapy Consumption Market Share by Countries (2015-2020)
Table 31. Americas Lentiviral Vector In Gene Therapy Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Lentiviral Vector In Gene Therapy Value Market Share by Countries (2015-2020)
Table 33. Americas Lentiviral Vector In Gene Therapy Consumption by Type (2015-2020) (K Units)
Table 34. Americas Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
Table 35. Americas Lentiviral Vector In Gene Therapy Consumption by Application (2015-2020) (K Units)
Table 36. Americas Lentiviral Vector In Gene Therapy Consumption Market Share by Application (2015-2020)
Table 37. APAC Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Lentiviral Vector In Gene Therapy Consumption Market Share by Countries (2015-2020)
Table 39. APAC Lentiviral Vector In Gene Therapy Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Lentiviral Vector In Gene Therapy Value Market Share by Regions (2015-2020)
Table 41. APAC Lentiviral Vector In Gene Therapy Consumption by Type (2015-2020) (K Units)
Table 42. APAC Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
Table 43. APAC Lentiviral Vector In Gene Therapy Consumption by Application (2015-2020) (K Units)
Table 44. APAC Lentiviral Vector In Gene Therapy Consumption Market Share by Application (2015-2020)
Table 45. Europe Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Lentiviral Vector In Gene Therapy Consumption Market Share by Countries (2015-2020)
Table 47. Europe Lentiviral Vector In Gene Therapy Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Lentiviral Vector In Gene Therapy Value Market Share by Countries (2015-2020)
Table 49. Europe Lentiviral Vector In Gene Therapy Consumption by Type (2015-2020) (K Units)
Table 50. Europe Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
Table 51. Europe Lentiviral Vector In Gene Therapy Consumption by Application (2015-2020) (K Units)
Table 52. Europe Lentiviral Vector In Gene Therapy Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Lentiviral Vector In Gene Therapy Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Lentiviral Vector In Gene Therapy Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Market Share by Application (2015-2020)
Table 61. Lentiviral Vector In Gene Therapy Distributors List
Table 62. Lentiviral Vector In Gene Therapy Customer List
Table 63. Global Lentiviral Vector In Gene Therapy Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Lentiviral Vector In Gene Therapy Consumption Market Forecast by Regions
Table 65. Global Lentiviral Vector In Gene Therapy Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Lentiviral Vector In Gene Therapy Value Market Share Forecast by Regions
Table 67. Global Lentiviral Vector In Gene Therapy Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Lentiviral Vector In Gene Therapy Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Lentiviral Vector In Gene Therapy Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Lentiviral Vector In Gene Therapy Value Market Share Forecast by Type (2021-2025)
Table 71. Global Lentiviral Vector In Gene Therapy Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Lentiviral Vector In Gene Therapy Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Lentiviral Vector In Gene Therapy Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Lentiviral Vector In Gene Therapy Value Market Share Forecast by Application (2021-2025)
Table 75. Thermo Fisher Scientific Sirion-Biotech GmbH Product Offered
Table 76. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Thermo Fisher Scientific Sirion-Biotech GmbH Main Business
Table 78. Thermo Fisher Scientific Sirion-Biotech GmbH Latest Developments
Table 79. Thermo Fisher Scientific Sirion-Biotech GmbH Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 80. Vigene Biosciences Product Offered
Table 81. Vigene Biosciences Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Vigene Biosciences Main Business
Table 83. Vigene Biosciences Latest Developments
Table 84. Vigene Biosciences Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 85. SignaGen Laboratories Product Offered
Table 86. SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. SignaGen Laboratories Main Business
Table 88. SignaGen Laboratories Latest Developments
Table 89. SignaGen Laboratories Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Takara Bio Product Offered
Table 91. Takara Bio Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Takara Bio Main Business
Table 93. Takara Bio Latest Developments
Table 94. Takara Bio Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 95. OriGene Technologies Product Offered
Table 96. OriGene Technologies Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. OriGene Technologies Main Business
Table 98. OriGene Technologies Latest Developments
Table 99. OriGene Technologies Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 100. GENEMEDI Product Offered
Table 101. GENEMEDI Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. GENEMEDI Main Business
Table 103. GENEMEDI Latest Developments
Table 104. GENEMEDI Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Cell Biolabs Product Offered
Table 106. Cell Biolabs Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 107. Cell Biolabs Main Business
Table 108. Cell Biolabs Latest Developments
Table 109. Cell Biolabs Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. Bluebird Bio Product Offered
Table 111. Bluebird Bio Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Bluebird Bio Main Business
Table 113. Bluebird Bio Latest Developments
Table 114. Bluebird Bio Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 115. GenTarget Product Offered
Table 116. GenTarget Lentiviral Vector In Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. GenTarget Main Business
Table 118. GenTarget Latest Developments
Table 119. GenTarget Basic Information, Company Total Revenue (in $ million), Lentiviral Vector In Gene Therapy Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Lentiviral Vector In Gene Therapy
Figure 2. Lentiviral Vector In Gene Therapy Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Lentiviral Vector In Gene Therapy Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Lentiviral Vector In Gene Therapy Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Retrovirus (RV)
Figure 7. Product Picture of Adenovirus (AdV)
Figure 8. Product Picture of Adeno-associated Virus (AAV)
Figure 9. Global Lentiviral Vector In Gene Therapy Consumption Market Share by Type (2015-2020)
Figure 10. Global Lentiviral Vector In Gene Therapy Value Market Share by Type (2015-2020)
Figure 11. Lentiviral Vector In Gene Therapy Consumed in Hospital
Figure 12. Global Lentiviral Vector In Gene Therapy Market: Hospital (2015-2020) (K Units)
Figure 13. Global Lentiviral Vector In Gene Therapy Market: Hospital (2015-2020) ($ Millions)
Figure 14. Lentiviral Vector In Gene Therapy Consumed in Clinic
Figure 15. Global Lentiviral Vector In Gene Therapy Market: Clinic (2015-2020) (K Units)
Figure 16. Global Lentiviral Vector In Gene Therapy Market: Clinic (2015-2020) ($ Millions)
Figure 17. Lentiviral Vector In Gene Therapy Consumed in Research Institution
Figure 18. Global Lentiviral Vector In Gene Therapy Market: Research Institution (2015-2020) (K Units)
Figure 19. Global Lentiviral Vector In Gene Therapy Market: Research Institution (2015-2020) ($ Millions)
Figure 20. Lentiviral Vector In Gene Therapy Consumed in Others
Figure 21. Global Lentiviral Vector In Gene Therapy Market: Others (2015-2020) (K Units)
Figure 22. Global Lentiviral Vector In Gene Therapy Market: Others (2015-2020) ($ Millions)
Figure 23. Global Lentiviral Vector In Gene Therapy Consumption Market Share by Application (2015-2020)
Figure 24. Global Lentiviral Vector In Gene Therapy Value Market Share by Application (2015-2020)
Figure 25. Global Lentiviral Vector In Gene Therapy Sales Market Share by Company in 2017
Figure 26. Global Lentiviral Vector In Gene Therapy Sales Market Share by Company in 2019
Figure 27. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Company in 2017
Figure 28. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Company in 2019
Figure 29. Global Lentiviral Vector In Gene Therapy Sale Price by Company in 2019
Figure 30. Global Lentiviral Vector In Gene Therapy Consumption Market Share by Regions 2015-2020
Figure 31. Global Lentiviral Vector In Gene Therapy Value Market Share by Regions 2015-2020
Figure 32. Americas Lentiviral Vector In Gene Therapy Consumption 2015-2020 (K Units)
Figure 33. Americas Lentiviral Vector In Gene Therapy Value 2015-2020 ($ Millions)
Figure 34. APAC Lentiviral Vector In Gene Therapy Consumption 2015-2020 (K Units)
Figure 35. APAC Lentiviral Vector In Gene Therapy Value 2015-2020 ($ Millions)
Figure 36. Europe Lentiviral Vector In Gene Therapy Consumption 2015-2020 (K Units)
Figure 37. Europe Lentiviral Vector In Gene Therapy Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Lentiviral Vector In Gene Therapy Value 2015-2020 ($ Millions)
Figure 40. Americas Lentiviral Vector In Gene Therapy Consumption Market Share by Countries in 2019
Figure 41. Americas Lentiviral Vector In Gene Therapy Value Market Share by Countries in 2019
Figure 42. Americas Lentiviral Vector In Gene Therapy Consumption Market Share by Type in 2019
Figure 43. Americas Lentiviral Vector In Gene Therapy Consumption Market Share by Application in 2019
Figure 44. United States Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 45. United States Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Lentiviral Vector In Gene Therapy Consumption Market Share by Countries in 2019
Figure 51. APAC Lentiviral Vector In Gene Therapy Value Market Share by Regions in 2019
Figure 52. APAC Lentiviral Vector In Gene Therapy Consumption Market Share by Type in 2019
Figure 53. APAC Lentiviral Vector In Gene Therapy Consumption Market Share by Application in 2019
Figure 54. China Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 55. China Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 62. India Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 63. India Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Lentiviral Vector In Gene Therapy Consumption Market Share by Countries in 2019
Figure 67. Europe Lentiviral Vector In Gene Therapy Value Market Share by Countries in 2019
Figure 68. Europe Lentiviral Vector In Gene Therapy Consumption Market Share by Type in 2019
Figure 69. Europe Lentiviral Vector In Gene Therapy Consumption Market Share by Application in 2019
Figure 70. Germany Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 72. France Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 73. France Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 74. UK Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 75. UK Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Lentiviral Vector In Gene Therapy Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption Market Share by Application in 2019
Figure 84. Egypt Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Lentiviral Vector In Gene Therapy Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Lentiviral Vector In Gene Therapy Value Growth 2015-2020 ($ Millions)
Figure 94. Global Lentiviral Vector In Gene Therapy Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Lentiviral Vector In Gene Therapy Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 97. Americas Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 98. APAC Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 99. APAC Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 100. Europe Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 101. Europe Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 104. United States Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 105. United States Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 106. Canada Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 107. Canada Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 108. Mexico Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 109. Mexico Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 110. Brazil Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 111. Brazil Lentiviral Vector In Gene Therapy Value 2021-2025 ($ Millions)
Figure 112. China Lentiviral Vector In Gene Therapy Consumption 2021-2025 (K Units)
Figure 113. China Lentiviral Vector In Gene Therapy Value 202
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs